Related Experiment Video
Updated: May 5, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Cyclodextrin/PVP-Based Nanofibers with Rhadiola rosea Extract as a New System for Increasing Bioavailability of
Maciej Jaskólski1, Magdalena Paczkowska-Walendowska1, Zuzanna Rybarczyk1
1Department of Pharmacognosy and Biomaterials, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Abstract:
The present study aimed to optimize the extraction process for Rhodiola rosea root, then develop and optimize electrospun nanofiber systems containing extract to enhance the bioavailability of its active compounds, salidroside and rosarin. Using a Design of Experiments (DoE) approach, nanofibers were prepared with varying ratios of polyvinylpyrrolidone (PVP) and hydroxypropyl-cyclodextrins (HPαCD, HPβCD, HPγCD). The systems were comprehensively characterized in terms of morphology, content of active compounds, dissolution rate, permeability, mucoadhesion, antioxidant, and anti-inflammatory activities. The results showed that nanofiber formulations significantly improved the dissolution and permeability of salidroside and rosarin compared to the crude extract. The antioxidant properties were notably enhanced, while the anti-inflammatory activity varied depending on composition. The formulation containing 3 g HPβCD and 2.5 g PVP demonstrated the most favorable balance of functional and technological properties. Principal Component Analysis (PCA) and correlation matrix analysis confirmed that system composition strongly influenced the interrelationships between technological parameters and bioactivity. These findings indicate that electrospun nanofibers based on cyclodextrin-PVP matrices are a promising preclinical strategy for improving the delivery of Rhodiola rosea bioactives.
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Bioavailability
Site-Targeted Drug Delivery Systems: Polymeric Carriers

